Close

10 Governors in attendance at the 2013 BIO International Convention

Governor Dennis Daugaard, South Dakota; Governor Jay Nixon, Missouri; Governor Rick Perry, Texas; Governor Tom Corbett, Pennsylvania networking and discussing the future of biotech.

Hans Schikan, CEO of Prosensa, on Rare Disease Drug Development

At the BIO CEO & Investor Conference in New York, BIO had the opportunity to speak with Hans Schikan, CEO of Prosensa, a company that targets rare diseases -- in particular Duchenne Muscular Dystrophy. He highlighted the important role patient advocacy organizations play in his company's drug development process and the industry's goal to help save lives and improve quality of life.

U.S. Rep. Charlie Dent Discusses the Biotech Industry's Presence in Pennsylvania

U.S. Rep. Charlie Dent discusses Pennsylvania's biotechnology industry with the Biotechnology Industry Organization's Fritz Bittenbender.

Rachel King, CEO of GlycoMimetics, Discusses Partnering and Public Policy

Mike Huckman, former CNBC anchor and Chief Strategist with Pure Communications, discuss business partnering and and public policy during the BIO CEO & Investor conference in New York

"Innovation Is..." with Ron Cohen MD, President and Chief Executive Officer, Acorda Therapeutics, Inc.

Ron Cohen MD, President and Chief Executive Officer, Acorda Therapeutics, Inc., discusses what is necessary to create an environment of biotech innovation.

Can Innovation Bridge the Partisan Divide?

CSBI held an Innovation Forum on 12/12/13 to discuss the future of small business innovation in the U.S. and how Congress can support breakthrough research. Leading thinkers from early-stage tech industries shared their thoughts on innovative R&D, the investment ecosystem, and the political climate. Check out the highlights here!

Fireside Chat with Jan M. Lundberg, PhD, President, Lilly Research Laboratories

BIO featured Jan Lundberg of Eli Lilly as this year's fireside chat speaker at the BIO Investor Forum!

"Innovation is..." with Stephan Tanda, Managing Board Member with Royal DSM

Stephan Tanda, Managing Board Member with Royal DSM, discusses what is necessary to create an environment of biotech innovation.

Exhibitor Hospitality Receptions: Highlights from Tuesday Evening

Wigs, roses, bourbon, and bikes are just a taste of what was happening at the Exhibitor Hospitality Receptions on Tuesday evening as BIO attendees loosened their ties, kicked off their heels, and hit the BIO Exhibition floor at the 2013 BIO International Convention.

Dr. Mathias Kremer, Head of Global Seeds, Bayer CropScience discusses the history of their business.

Dr. Mathias Kremer, Head of Global Seeds, Bayer CropScience discusses the history of their business at the 2013 BIO International Convention.